Zobrazeno 1 - 10
of 38
pro vyhledávání: '"L. E. Bulychev"'
Autor:
A. S. Zamedyanskaya, Al. A. Sergeev, K. A. Titova, A. S. Kabanov, L. E. Bulychev, Ar. A. Sergeev, A. E. Nesterov, O. V. Nosareva, D. O. Galakhova, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1, Pp 75-78 (2016)
Objective of the study is to investigate the sensitivity of different animals to highly pathogenic Orthopoxviruses applying techniques, based on utilization of primary cultures of lung cells, and to assess the possibility of further deployment of thi
Externí odkaz:
https://doaj.org/article/dd9f597aece14c038df1adf618d2cad7
Autor:
D. O. Galakhova, Ar. A. Sergeev, E. V. Shevtsova, Al. A. Sergeev, A. S. Zamedyanskaya, K. A. Titova, L. N. Shishkina, L. E. Bulychev, S. V. Borisevich, V. N. Podkuiko, A. P. Pirozhkov, A. V. Koval’Chuk, Ya. V. Polyansky, E. Yu. Vakhnov, V. V. Perekrest, V. A. Shevtsov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1, Pp 84-89 (2016)
Objective of the investigation was to model the adverse action of vaccinia virus (VV), caused by oral immunization of mice and to evaluate efficacy of its reduction, using therapeutic and prophylactic drugs. Materials and methods. Virological and imm
Externí odkaz:
https://doaj.org/article/2f2e4a61775149329dc1cadbb24582a5
Autor:
K. A. Titova, Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, Ar. A. Sergeev, D. O. Galahova, A. S. Zamedyanskaya, L. N. Shishkina, O. S. Taranov, V. V. Omigov, E. L. Zavjalov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 19, Iss 4, Pp 487-493 (2015)
At present, there is no animal model for smallpox that reflects the weakened immune system in people and can therefore help assess the prophylactic (highly preventive) efficiency of antiviral drugs. To fill in the gap, we have explored the possibilit
Externí odkaz:
https://doaj.org/article/9bb5088aad6642b2a9041610de31713f
Autor:
Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, O. V. P’Yankov, Ar. A. Sergeev, S. A. Bodnev, D. O. Gorbatovskaya, A. S. Zamedyanskaya, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 4, Pp 86-90 (2015)
By the experiments of in vivo intranasal infection of 8-10-days-old outbread ICR mice with Monkeypox virus (MPV) in a dose equal 3.83 lg FFU/specimen, investigated was dynamics of the virus accumulation within various organs, blood cells, and blood s
Externí odkaz:
https://doaj.org/article/31647faedd1e46d4a264605086d2cff7
Autor:
Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, O. V. P’Yankov, Ar. A. Sergeev, O. S. Taranov, S. A. Bodnev, Yu. V. Tumanov, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 2, Pp 60-65 (2013)
of MPV after 7 days postinfection, applying peroral administration once within 24 hours (24 hours before infection and 7 days after infection of mouse with 60 µg/g of a preparation). Displayed is the feasibility of using 8–15-days-old ICR mice (bo
Externí odkaz:
https://doaj.org/article/57e9151a7ab5456cae87a7b636828c92
Autor:
A. S. Kabanov, Al. A. Sergeev, L. E. Bulychev, N. I. Bormotov, L. N. Shishkina, Ar. A. Sergeev, S. A. Bodnev, M. O. Skarnovich, A. R. Shevtsov, B. A. Selivanov, A. Ya. Tikhonov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 2, Pp 54-59 (2013)
for ST-246 and NIOC-14 is within the range of 0,001-0,004 µg/ml, and IS for both of them is > 100000. In addition, ST-246 and NIOC-14 chemical compound efficacy, concentrated up to 0,0125; 0,025 and 0,05 µg/ml, in accordance with prophylactic chart
Externí odkaz:
https://doaj.org/article/8945cae60ae645d0a1ef3cc30e4c8e17
Autor:
Al. A. Sergeev, L. E. Bulychev, O. V. P'yankov, Ar. A. Sergeev, S. A. Bodnev, A. S. Kabanov, Yu. V. Tumanov, I. A. Yurganova, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1(111), Pp 88-91 (2012)
Studied is the sensitivity of different animal species (white mice, rabbits, mini-pigs, and marmots) to Monkeypox virus (MPXV). Determined is the fact that MPXV-sensitive are groundhogs (ID50 and LD50 5 lg of PFU in case of intranasal inoculation). T
Externí odkaz:
https://doaj.org/article/42565c1848d042f3b9e9cccc1c02939a
Autor:
T. V. Teplyakova, L. E. Bulychev, T. A. Kosogova, Zh. B. Ibragimova, I. A. Yurganova, A. S. Kabanov, L. I. Puchkova, N. I. Bormotov, A. V. Bardasheva
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3(113), Pp 99-101 (2012)
Carried out was evaluation of the effect of water extracts from basidiomycetes in Vero cell culture on variola virus, and vaccinia virus. Antiviral effect demonstrated Inonotus obliquus (Chaga), befungin and melanin from chaga, Ganoderma applanatum (
Externí odkaz:
https://doaj.org/article/7f8d3a41b1f842e8bf80c5693364db2a
Autor:
A A, Dolskiy, I V, Grishchenko, S A, Bodnev, A A, Nazarenko, A M, Smirnova, A K, Matveeva, L E, Bulychev, A S, Ovchinnikova, T V, Tregubchak, A V, Zaykovskaya, I R, Imatdinov, O V, Pyankov, E V, Gavrilova, R A, Maksyutov, D V, Yudkin
Publikováno v:
Molekuliarnaia biologiia. 56(3)
Coronaviridae is a family of single-stranded RNA (ssRNA) viruses that can cause diseases with high mortality rates. SARS-CoV-1 and MERS-CoV appeared in 2002-2003 and 2012, respectively. A novel coronavirus, SARS-CoV-2, emerged in 2019 in Wuhan (China
Autor:
A A, Dolskiy, I V, Grishchenko, S A, Bodnev, A A, Nazarenko, A M, Smirnova, A K, Matveeva, L E, Bulychev, A S, Ovchinnikova, T V, Tregubchak, A V, Zaykovskaya, I R, Imatdinov, O V, Pyankov, E V, Gavrilova, R A, Maksyutov, D V, Yudkin
Publikováno v:
Molecular biology. 56(3)
Coronaviridae is a family of single-stranded RNA (ssRNA) viruses that can cause diseases with high mortality rates. SARS-CoV-1 and MERS-CoV appeared in 2002‒2003 and 2012, respectively. A novel coronavirus, SARS-CoV-2, emerged in 2019 in Wuhan (Chi